Transient Receptor Potential channel subfamily A member 1 (TRPA1) is a non selective cationic channel, identified initially as a cold sensory receptor. TRPA1 responds to diverse exogenous and endogenous stimuli associated with pain and inflammation. However, the role of TRPA1 towards T cell responses remains scanty. In this work, we explored the endogenous expression of TRPA1 in T cells. By RT-PCR we confirmed the expression of TRPA1 in T cell at RNA level. Using confocal microscopy as well as flow cytometry, we demonstrated that TRPA1 is endogenously expressed in primary murine splenic T cells as well as in primary human T cells. The endogenous expression of TRPA1 is confirmed by using another antibody. TRPA1 was primarily located at the cell surface. 
Abstract:
Transient Receptor Potential channel subfamily A member 1 (TRPA1) is a non selective cationic channel, identified initially as a cold sensory receptor. TRPA1 responds to diverse exogenous and endogenous stimuli associated with pain and inflammation. However, the role of TRPA1 towards T cell responses remains scanty. In this work, we explored the endogenous expression of TRPA1 in T cells. By RT-PCR we confirmed the expression of TRPA1 in T cell at RNA level. Using confocal microscopy as well as flow cytometry, we demonstrated that TRPA1 is endogenously expressed in primary murine splenic T cells as well as in primary human T cells. The endogenous expression of TRPA1 is confirmed by using another antibody. TRPA1 was primarily located at the cell surface. 
Introduction:
Transient receptor potential cation channel subfamily A member 1 (TRPA1) is the only member of the mammalian 'ankyrin' type subfamily of TRP channels [1] . TRPA1 is a Ca 2+ -permeable nonselective cation channel that is expressed in a set of nociceptive/thermo-receptive neurons that can detect noxious cold temperature below 17°C. It is often co-expressed with the heat-sensitive channel TRPV1 rather than with the cold-sensitive channel TRPM8. Initial reports suggested that the large influx of Ca 2+ ions at lower temperatures (such as at 10°C) is primarily due to the direct activation of this channel by cold stimuli [2, 3] . Apart from low temperature as a stimulus, TRPA1 also acts as a nociceptive receptor that detects noxious chemicals that can cause tissue damage. TRPA1 also acts as a mediator of inflammatory pain generated by either noxious cold or chemical irritants [4, 5] .
Ca 2+ channels are an integral part of T cell activation, differentiation, and formation of an immunological synapse between mature CD4 + T cells and Antigen Presenting Cells (APC), and even exocytosis of vesicles in cytotoxic T cells. It also influences cytokine release patterns which in turn affect T cell functions like the development of anergy, maturation, and differentiation of naïve T cells into Th1 andTh2 cells [6] . In agreement with these reports, abnormality in Ca 2+ -signalling results in several immunological disorders such as SCID, Wiskott-Aldrich syndrome (WAS) [6] . T cell motility is also regulated by Ca 2+ in consortium with Protein Kinase C which regulates the rearrangement of actin cytoskeleton in them. Activation of several transcription factors such as NFAT, NF-κB, calmodulin-dependent kinase, JNK, and others are known to be involved in T cell regulation and require Ca 2+ ions [7] . Moreover, recently a strategic usage of cation channel blockers towards T cell activation, cytokine secretion, and proliferation has been demonstrated [8] . Transient Receptor Potential (TRP) channels act as Ca 2+ -permeable channels and thereby regulate Ca 2+ -homeostasis. So far few members of the TRP family members have been identified by us and other groups that are endogenously expressed in T cells and regulate T cell functions [9, 10] and us. In this work, we have probed for the expression and localization of the TRPA1 channel in T cells and explored its functional importance as well.
Endogenous inflammatory agents such as Reactive Oxygen Species (ROS) induce the production of 4-hydroxy-2-nonenal (HNE) that directly activates TRPA1 [9] . Nitrated fatty acids and prostaglandins like 15d-PGJ2 are released at the site of inflammation, and such compounds can also directly activate TRPA1 [10, 11] . It is also known that lymphoma and inflammation associated itch is mediated by a Th2 cell-derived cytokine, interleukin-31 (IL-31), that directly interacts with its receptor IL-31RA located on TRPV1 + /TRPA1 + sensory nerves in skin [12] . These compounds can also play a role in T cell activation. In addition, LPS (a noxious by-product of gram-negative bacteria) activates TRPA1 via a TLR-4 independent mechanism and thereby generates a rapid nociceptive response and neurogenic inflammation [13] . In this work, we have probed for the expression, localization of TRPA1 channel in T cells and also characterized the function of TRPA1 towards T cell activation. 
Materials and Methods

RNA isolation and qPCR:
Approximately 3-5 x 10 6 T cells were used for RNA isolation. For positive control, spinal cord tissue from mice was used. RNA isolation was done using TRIzol reagent according to the manufacturer`s instructions. Nanodrop readings were taken and 1 g of RNA was converted to cDNA using verso cDNA synthesis kit as per the mentioned protocol. RTPCR reactions were performed for TRPA1 and GAPDH in ABI7500 system (Applied Biosystems, Foster city, CA, USA) using 2X SYBR Green mix following the reaction gene expression was visualized in 1 % agarose gel.
Flow cytometry: Flow cytometry analysis of T cells was performed as described previously [14] . For probing for TRPA1 expression, cells were stained with the TRPA1-specific antibody mentioned before and subsequently flow cytometric analysis was performed as described previously [14, 15] . Immunofluorescence analysis and microscopy: Immunofluorescence analysis of T cells was performed as described previously [14] . For immunocytochemical analysis, immediately after harvesting, T cells were diluted in PBS and fixed with paraformaldehyde (final concentration 2%). After fixing the cells with paraformaldehyde, immunostaining was done by two procedures: in first case cell permeabilization was not performed as the antibody detecting TRPA1 recognizes an extracellular region of TRPA1. In other cases, the cells were permeabilized with 0.1% Triton X-100 in PBS (5 min).
Subsequently, the cells were blocked with 5% BSA for 1 hour. The primary antibodies were used at 1: 400 dilutions. In some experiments, blocking peptides were used to confirm the specificity of the immunoreactivity. The ratio of blocking peptides with specific antibody was 1: 1 (in concentration).
Another rabbit polyclonal antibody (procured from Novus Biologicals) detecting epitope present in the N-terminal cytoplasmic domain of TRPA1 was used (1:1000 dilution) in some experiments to confirm the endogenous expression of TRPA1 in T cells. All primary antibodies were incubated overnight at 4°C in PBST buffer (PBS supplemented with 0.1% Tween-20 ELISA: Supernatants from the respective experiments were collected and stored at -80°C. ELISA for different T cell effector cytokines TNF, IL-2 and IFNγ were performed using BD Biosciences Sandwich ELISA kits (San Jose, CA, USA) as per the manufacturer's instructions. The readings were acquired using a microplate reader (Bio-Rad iMARK) at 450 nm.
Statistical tests:
The primary data were imported into R software for statistical analysis. The ANOVA test was done for each data set to check the reliability and significance. The P value of < 0.05 was considered statistically significant. Data presented here are representative of three independent experiments. The significance values are as follows: *** = P between 0 and 0.001; ** = P between 0.001 and 0.01; * = P between 0.01 and 0.05; ns = P above 0.05.
Results:
TRPA1 is expressed endogenously in primary murine and human T cells Expression of TRPA1 in mRNA level in T cell is confirmed by RT-PCR (Fig. 1a) . The surface expressions of specific ion channels are critical for signaling events. We used a specific antibody (Almone lab) for which the epitope is present at the extracellular loop-1 of TRPA1 (i.e., present outside the cell surface). Therefore this antibody allowed us to probe for the surface expression of TRPA1 (in un-permeabilized cells) and as well as total TRPA1 expression (in Triton X-100-permeabilized cells).
We probed the surface expression of TRPA1 in unpermeabilized cells. This antibody detects TRPA1 signal in the surface of unpermealized T cells (Fig 1b) . We probed surface as well as total expression of TRPA1 in murine T cells that are at resting (naïve) stage and/or activated with either the mitogen Concanavalin A (ConA, a lectin that acts as a mitogen and results in T cell activation) or by T cell
Receptor (TCR) stimulation with α-CD3/α-CD28 antibodies [17, 18] .
Further confocal microscopy analysis revealed that TRPA1 is endogenously expressed in resting and activated T cells as distinct clusters that are primarily located at the cell surface (Fig. 1c) .
Notably, the TRPA1 signal was blocked upon pre-incubating the antibodies with their antigenic peptide confirming the specificity of the antibody used (Fig. 1c) . The intracellular localization of TRPA1 was almost minimal as there was no significant difference in its expression in surface versus in whole cell (in resting conditions). However, all the T cells do not express TRPA1 at resting state. Flow cytometry results suggest that the expression level of TRPA1 was increased in Con A activated and in TCR activated T cells (Fig. 1d & 1e) .
To confirm the endogenous expression of TRPA1 in T cell, we used another antibody (Novus Biologicals) raised against epitope present in the N-terminal cytoplasmic domain of TRPA1. This antibody detects TRPA1 modestly in resting T cells and strongly in ConA-treated T cells, but after permeabilization (Fig. 1f) . This antibody does not detect TRPA1 in unpermeabilized T cells. Taken together, the data strongly suggest that TRPA1 is endogenously expressed in murine T cells.
Similar to murine T cells, human PBMC-derived T cells also show TCR and ConA activation driven increased expression of TRPA1 (Fig. 2) . The Z-section images showed increase in TRPA1 at the surface on T cell activation by ConA or TCR (Fig. 2) . These qualitative and quantitative data strongly suggest for endogenous expression of TRPA1 in T cells and increased surface expression of TRPA1 correlates with T cell activation process.
TRPA1 activation induces increased Ca 2+ level in T cells
In order to explore if the TRPA1 present in T cells are functional, we performed Ca 2+ -imaging experiments (Fig. 3) . For that purpose, we have used purified mouse T cells loaded with Fluo-4 AM.
Live cell imaging revealed that in the absence of any stimuli, there is no increase in Fluo-4 intensity in the majority of the cells with respect to time. However, upon stimulation by TRPA1 activator AITC, intracellular Ca 2+ level increase in most of the T cells (Fig 3a) . This AITC-mediated increase in Ca 2+ -level was effectively blocked by TRPA1-specific inhibitors A-967079, and HC-030031 (Fig 3& 4) .
Calcium chelation experiments with BAPTA-AM as well as by EGTA (present in extracellular media)
suggest that TRPA1 regulates Ca 2+ influx from both extracellular and intracellular reserves (Fig 4) .
Similarly, the level of intracellular Ca 2+ -goes down after adding the inhibitor in activator (AITC) treated cells (Fig 4f) . To confirm all these effects in a more quantitatively, we compared the level of Ca 2+ in T cells just before and after adding the TRPA1 modulatory drugs (Fig 4g) . Such analysis clearly suggest the changes in the fluorescence intensity in quick time. This confirmed that functional TRPA1 is expressed in T cells.
TRPA1 is involved in ConA/TCR-mediated T cell activation and effector cytokine secretion
In order to explore the role of TRPA1 in T cell activation, we have activated the cells either by (Fig. 5a, c) . In that condition (after treatment with both ConA and (Fig. 5b, 5d ).
T cell activation involves an increased level of secretion of several effector cytokines like TNF,
IFNγ, and IL-2. We explored the role of TRPA1 in the production of these cytokines by analyzing the culture supernatants by ELISA (Fig. 5e) . TCR stimulation induced high levels of TNF (Resting condition: 151.8±94.88 pg/ml; TCR-mediated activated condition: 2931.98±220.85 pg/ml) while inhibition of TRPA1 by A-967079 blocked the effect of these stimulators on TNF production (TCR + A-967079 combination: 597.74±71.83 pg/ml) (Fig. 5e) . TRPA1 inhibition also blocked IL-2 secretion (Resting: 62±37.91 pg/ml; TCR: 1067.4 ± 267.003 pg/ml; TCR + A-967079 combination:
200.33±83.25 pg/ml) (Fig. 5e) . Moreover IFNγ production was down-regulated by A-967079 treatment (Resting: 912.83±216.20pg/ml; TCR: 10279.5 ± 2702.65 pg/ml; TCR + A-967079 combination:
1421.72±599.3 pg/ml) (Fig. 5e) . Taken together the results indicate that TRPA1 is expressed in T cells and may positively regulate T cell activation and effector cytokine release.
Discussion:
T cell activation involves several distinct signaling events, and the influx of Ca 2+ -ions is vital during this process. However, so far only a few Ca 2+ channels have been detected in T cells, whereas the identity of the major Ca 2+ channels present in T cells is unknown. In addition, the mode of regulation of these channels and their exact role in the context of T cell functions are mostly unknown. TRPA1
can be activated by several means and also by endogenous factors. Though TRPA1 has been considered as a "cold-activated ion channel," it's true thermosensitive nature is debatable. For example, it has been shown that TRPA1 is not directly gated by cold but rather gated by increased intracellular Ca 2+ -levels as a consequence of cooling [19] . It is important to mention that Ca 2+ ions directly gate hTRPA1 in a PLC-independent fashion. This is confirmed by the fact that TRPA1 shows Ca 2+ -induced currents even after treatment with the PLC-blocker U73122 (10 µM) [3] .
In this work, we demonstrated that functional TRPA1, a non-selective cation channel is expressed in the human and murine T cells. Our results suggest that TRPA1 plays an important role relevant for T cell activation, likely by different endogenous factors. In a recent report, the functional expression of TRPA1 in murine and human CD4 + T cells has been shown to regulate T cell activation and pro-inflammatory responses [20] . However, the previous reports have suggested a proinflammatory role of TRPA1 towards immune activation and inflammation [21] . So far, TRPA1 has been considered as one of the critical regulators of neurogenic inflammation and neuropeptide release [22] . It has also been reported that TRPA1 is associated with inflammation and puritogen responses in dermatitis [23] . In fact expression of TRPA1 in the peripheral sensory neurons and its involvement in the neural excitation has been demonstrated. However, limited information is available currently about the expression and role of TRPA1 in non-neuronal cells. The association of TRP channels towards inflammation and immunogenic responses has been largely found to be positively regulated during the immune-physiology of the cellular and systemic responses. TRPA1 has been reported to contribute to the inflammation induced pain and associated experimental colitis in mice models [23] [24] [25] [26] .
Interestingly, recently it has been reported that CD4 + T cell-associated TRPA1 may regulate inflammation in experimental colitis model in mice [20] . However, evidence for any such functional requirement of TRPA1 in T cell responses, in vitro, remains scanty.
In this work, the endogenous expression of TRPA1 in primary murine and human T cell was observed by using two different TRPA1 specific antibodies. Expression of TRPA1 was found to be mostly predominant at the surface of these cells rather than being present in intracellular regions. We also provided evidence for the functional role of TRPA1 in immune functions. Flow cytometric analysis coupled with confocal imaging conclusively suggested enhanced expression of TRPA1 (both at surface level and in total) in activated T cells as compared to resting conditions. TRPA1 activation by specific ligands leads to increased intracellular Ca 2+ concentration in purified murine T cells, confirming that this channel is present in a functional form in resting T cells. Inhibition of TRPA1 by its specific inhibitor reduces TCR and Con A-driven mitogenic activation of T cells. This suggests that TRPA1 might be involved in the signaling pathways towards T cell activation and thus inhibiting TRPA1 activity has profound inhibitory effects on CD25 and CD69 expression together with the secretion of signature effector cytokines such as TNF, IFN-γ, and IL-2. TNF production is associated with several pro-inflammatory responses [27] . Additionally TNF is shown to be a major mediator of different inflammatory disease conditions like colitis and rheumatoid arthritis (RA) [28, 29] . TRPA1 channel expression is found to be increased in peripheral blood leukocytes of RA patients and associated with pain [30] . Moreover, it has been shown that TRPA1 facilitates TNF directed inflammatory responses in various pathophysiological conditions and blockade of TRPA1 receptors may be beneficial in reducing TNF induced the chronic pain [31, 32] . Interestingly, it has been shown that TRPA1 -/-T cells may produce higher IL-2 and IFN-γ but not TNF during TCR stimulation [20] . Functional role of IFN-γ as a signature Th1 cytokine is also implicated in pro-inflammatory responses and disease conditions like colitis [33] . However, there are some reports which suggest an anti-inflammatory role of IFN-γ in the mouse model of colitis [34, 35] . Apparently, these reports indicate that these cytokines may differentially regulate inflammatory responses in different disease conditions. Interestingly, we have found that during in vitro TCR activation the induction of signature Th1 and pro-inflammatory cytokines like IL-2, IFN-γ, and TNF could be down-regulated by the TRPA1 specific inhibitor, A-967079. Moreover, ConA and TCR stimulated induction of T cell activation markers like CD25 and CD69 were also found to be downregulated in presence A-967079. TRPA1 upon activation by its specific activator (AITC) was found to increase the Ca 2+ -levels, while two different inhibitors namely A-967079 and HC-030031 are able to reduce the intracellular Ca 2+ -levels. Therefore, it seems that during T cell activation, TRPA1 becomes functional and shows augmented expression and executes immune-regulatory functions, whereas, inhibition of this channel inhibits T cell activation. Recent report demonstrating the activation of TRPA1 by specific microRNA can also be relevant for T cell activation [36] . While our current work confirms the functional expression of TRPA1 channel and its requirement towards T cell activation, the involvement of this ion channel in T cell activation process associated with inflammatory diseases needs further investigation.
In (d). Application of AITC on population preincubated with HC-030031 fails to increase the basal Ca 2+ -levels (e). Application of HC-030031 after AITC results in initial rise (due to activation) followed by reduction (due to inhibition) of the basal Ca 2+ -levels (f). In each case, the DIC image represents the number and morphology of cells in the view-field at the end of the experiments (200 th frame). g. Quantification of basal Ca 2+ -levels in multiple cells before and after addition of TRPA1 modulatory agents. The maximum time gap between these two measurements are ~5 sec. **** indicates P value = ˂0.0001. For more details see supplementary movies. 
